BeStock  
Markets › Compare › PHAR vs LTGO

PHAR vs LTGO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PHAR · Pharming Group$11.54 ▼ 5.18%
LTGO · Latigo Biotherapeutics$13.00 ▼ 1.81%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6584103122141Aug 7, '26Sep 30, '26Nov 20, '26
  • PHAR +5.4%
  • LTGO -28.8%

Head to head

MetricPHARLTGO
Price$11.54$13.00
Change today▼ 5.18%▼ 1.81%
Market cap$816.78M$861.89M
Return, 3 months+0.7%-40.9%
Return, year to date-34.7%–
Return, 1 year-29.0%–
P/E (TTM)35.0–
P/B2.82.2
P/E percentile vs own 5y77th89th
Dividend yield––
Revenue growth (YoY, latest qtr)+20.8%–
Net profit growth (YoY)+197.1%+15.5%
Gross margin85.1%–
Operating margin6.7%–
Net margin6.3%–
Return on equity8.7%-27.2%
Analyst target vs. price+238.0%+343.6%
Analyst buy share100%100%
RSI (14)4541
30-day volatility59.3%84.6%
Max drawdown, 1 year-57.0%-49.6%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • LTGO is the largest of the group by market value.
  • PHAR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top